HIT Consultant May 10, 2022
What You Should Know:
– OncoHost, an AI-powered precision oncology platform, today announced a $35M Series C funding round led by ALIVE Israel HealthTech VC, as well as other prominent investors. Additional investors included leading Israeli financial firm Leumi Partners, Israel’s largest pension fund Menora Mivtachim, OurCrowd and other existing investors.
– The funding will go towards expanding OncoHost’s ongoing multicenter PROPHETIC trial as well as support its upcoming U.S. commercial launch.
A New Dimension of Cancer Care
All cancer treatment modalities such as immunotherapy, chemotherapy, targeted drugs, radiation and surgery trigger physiological reactions in the host comprising a range of systemic and local effects. These effects, collectively known as the ‘Host Response’ to cancer therapy, include elevated levels of...
Today's Sponsors
Today's Sponsor